ID   KAD1_HUMAN              Reviewed;         194 AA.
AC   P00568; Q9BVK9; Q9UQC7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 3.
DT   12-APR-2017, entry version 186.
DE   RecName: Full=Adenylate kinase isoenzyme 1 {ECO:0000255|HAMAP-Rule:MF_03171};
DE            Short=AK 1 {ECO:0000255|HAMAP-Rule:MF_03171};
DE            EC=2.7.4.3 {ECO:0000255|HAMAP-Rule:MF_03171};
DE            EC=2.7.4.6 {ECO:0000255|HAMAP-Rule:MF_03171};
DE   AltName: Full=ATP-AMP transphosphorylase 1 {ECO:0000255|HAMAP-Rule:MF_03171};
DE   AltName: Full=ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03171};
DE   AltName: Full=Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03171};
DE   AltName: Full=Myokinase {ECO:0000255|HAMAP-Rule:MF_03171};
GN   Name=AK1 {ECO:0000255|HAMAP-Rule:MF_03171};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PROTEIN SEQUENCE, AND ACETYLATION AT MET-1.
RC   TISSUE=Skeletal muscle;
RX   PubMed=183954; DOI=10.1111/j.1432-1033.1976.tb10787.x;
RA   von Zabern I., Wittmann-Liebold B., Untucht-Grau R., Schirmer R.H.,
RA   Pai E.F.;
RT   "Primary and tertiary structure of the principal human adenylate
RT   kinase.";
RL   Eur. J. Biochem. 68:281-290(1976).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HAAKD TRP-128.
RX   PubMed=2542324;
RA   Matsuura S., Igarashi M., Tanizawa Y., Yamada M., Kishi F., Kajii T.,
RA   Fujii H., Miwa S., Sakurai M., Nakazawa A.;
RT   "Human adenylate kinase deficiency associated with hemolytic anemia. A
RT   single base substitution affecting solubility and catalytic activity
RT   of the cytosolic adenylate kinase.";
RL   J. Biol. Chem. 264:10148-10155(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RA   Noma T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 10-21; 32-44; 64-77; 89-97; 108-128; 156-166 AND
RP   172-194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23416111; DOI=10.1016/j.biocel.2013.02.004;
RA   Amiri M., Conserva F., Panayiotou C., Karlsson A., Solaroli N.;
RT   "The human adenylate kinase 9 is a nucleoside mono- and diphosphate
RT   kinase.";
RL   Int. J. Biochem. Cell Biol. 45:925-931(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH BI-SUBSTRATE
RP   ANALOG AP5A.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human AK1A in complex with AP5A.";
RL   Submitted (MAR-2007) to the PDB data bank.
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) IN COMPLEX WITH BI-SUBSTRATE
RP   ANALOG AP4A.
RG   Structural genomics consortium (SGC);
RT   "Structure of adenylate kinase 1 in complex with P1, P4-
RT   di(adenosine)tetraphosphate.";
RL   Submitted (DEC-2005) to the PDB data bank.
RN   [13]
RP   VARIANT HAAKD CYS-164.
RX   PubMed=9432020; DOI=10.1046/j.1365-2141.1997.4953299.x;
RA   Qualtieri A., Pedace V., Bisconte M.G., Bria M., Gulino B.,
RA   Andreoli V., Brancati C.;
RT   "Severe erythrocyte adenylate kinase deficiency due to homozygous
RT   A-->G substitution at codon 164 of human AK1 gene associated with
RT   chronic haemolytic anaemia.";
RL   Br. J. Haematol. 99:770-776(1997).
RN   [14]
RP   VARIANTS HAAKD ARG-40; ARG-64 AND ASP-140 DEL.
RX   PubMed=12649162; DOI=10.1182/blood-2002-07-2288;
RA   Corrons J.-L., Garcia E., Tusell J.J., Varughese K.I., West C.,
RA   Beutler E.;
RT   "Red cell adenylate kinase deficiency: molecular study of 3 new
RT   mutations (118G>A, 190G>A, and GAC deletion) associated with
RT   hereditary nonspherocytic hemolytic anemia.";
RL   Blood 102:353-356(2003).
CC   -!- FUNCTION: Catalyzes the reversible transfer of the terminal
CC       phosphate group between ATP and AMP. Also displays broad
CC       nucleoside diphosphate kinase activity. Plays an important role in
CC       cellular energy homeostasis and in adenine nucleotide metabolism.
CC       {ECO:0000255|HAMAP-Rule:MF_03171, ECO:0000269|PubMed:23416111}.
CC   -!- CATALYTIC ACTIVITY: ATP + AMP = 2 ADP. {ECO:0000255|HAMAP-
CC       Rule:MF_03171, ECO:0000269|PubMed:23416111}.
CC   -!- CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP +
CC       nucleoside triphosphate. {ECO:0000255|HAMAP-Rule:MF_03171,
CC       ECO:0000269|PubMed:23416111}.
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03171,
CC       ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- DOMAIN: Consists of three domains, a large central CORE domain and
CC       two small peripheral domains, NMPbind and LID, which undergo
CC       movements during catalysis. The LID domain closes over the site of
CC       phosphoryl transfer upon ATP binding. Assembling and dissambling
CC       the active center during each catalytic cycle provides an
CC       effective means to prevent ATP hydrolysis. {ECO:0000255|HAMAP-
CC       Rule:MF_03171, ECO:0000305|Ref.11, ECO:0000305|Ref.12}.
CC   -!- POLYMORPHISM: This enzyme represents the most common of at least
CC       five alleles. {ECO:0000305|PubMed:183954}.
CC   -!- DISEASE: Hemolytic anemia due to adenylate kinase deficiency
CC       (HAAKD) [MIM:612631]: A disease characterized by hemolytic anemia
CC       and undetectable erythrocyte adenylate kinase activity.
CC       {ECO:0000269|PubMed:12649162, ECO:0000269|PubMed:2542324,
CC       ECO:0000269|PubMed:9432020}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylate kinase family. AK1 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03171}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Adenylate kinase entry;
CC       URL="https://en.wikipedia.org/wiki/Adenylate_kinase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04809; AAA51686.1; -; Genomic_DNA.
DR   EMBL; AB021871; BAA78534.1; -; mRNA.
DR   EMBL; BT019580; AAV38387.1; -; mRNA.
DR   EMBL; BC001116; AAH01116.1; -; mRNA.
DR   CCDS; CCDS6881.1; -.
DR   PIR; A33508; KIHUA.
DR   RefSeq; NP_000467.1; NM_000476.2.
DR   RefSeq; NP_001305050.1; NM_001318121.1.
DR   RefSeq; XP_016869916.1; XM_017014427.1.
DR   RefSeq; XP_016869917.1; XM_017014428.1.
DR   UniGene; Hs.175473; -.
DR   PDB; 1Z83; X-ray; 1.90 A; A/B/C=1-193.
DR   PDB; 2C95; X-ray; 1.71 A; A/B=1-193.
DR   PDBsum; 1Z83; -.
DR   PDBsum; 2C95; -.
DR   ProteinModelPortal; P00568; -.
DR   SMR; P00568; -.
DR   BioGrid; 106706; 26.
DR   IntAct; P00568; 20.
DR   STRING; 9606.ENSP00000362249; -.
DR   ChEMBL; CHEMBL4925; -.
DR   DrugBank; DB01717; Bis(Adenosine)-5'-Pentaphosphate.
DR   iPTMnet; P00568; -.
DR   PhosphoSitePlus; P00568; -.
DR   SwissPalm; P00568; -.
DR   BioMuta; AK1; -.
DR   DMDM; 20178288; -.
DR   OGP; P00568; -.
DR   REPRODUCTION-2DPAGE; IPI00018342; -.
DR   UCD-2DPAGE; P00568; -.
DR   EPD; P00568; -.
DR   PaxDb; P00568; -.
DR   PeptideAtlas; P00568; -.
DR   PRIDE; P00568; -.
DR   TopDownProteomics; P00568; -.
DR   DNASU; 203; -.
DR   Ensembl; ENST00000373156; ENSP00000362249; ENSG00000106992.
DR   Ensembl; ENST00000373176; ENSP00000362271; ENSG00000106992.
DR   GeneID; 203; -.
DR   KEGG; hsa:203; -.
DR   CTD; 203; -.
DR   DisGeNET; 203; -.
DR   GeneCards; AK1; -.
DR   HGNC; HGNC:361; AK1.
DR   HPA; CAB009893; -.
DR   HPA; HPA006456; -.
DR   MalaCards; AK1; -.
DR   MIM; 103000; gene.
DR   MIM; 612631; phenotype.
DR   neXtProt; NX_P00568; -.
DR   OpenTargets; ENSG00000106992; -.
DR   Orphanet; 86817; Hemolytic anemia due to adenylate kinase deficiency.
DR   PharmGKB; PA24655; -.
DR   eggNOG; KOG3079; Eukaryota.
DR   eggNOG; COG0563; LUCA.
DR   GeneTree; ENSGT00390000016215; -.
DR   HOGENOM; HOG000238771; -.
DR   HOVERGEN; HBG108060; -.
DR   InParanoid; P00568; -.
DR   KO; K00939; -.
DR   PhylomeDB; P00568; -.
DR   TreeFam; TF354283; -.
DR   BRENDA; 2.7.4.3; 2681.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   SABIO-RK; P00568; -.
DR   EvolutionaryTrace; P00568; -.
DR   GenomeRNAi; 203; -.
DR   PRO; PR:P00568; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000106992; -.
DR   CleanEx; HS_AK1; -.
DR   ExpressionAtlas; P00568; baseline and differential.
DR   Genevisible; P00568; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004017; F:adenylate kinase activity; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB.
DR   GO; GO:0046034; P:ATP metabolic process; IEA:InterPro.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB.
DR   GO; GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB.
DR   CDD; cd01428; ADK; 1.
DR   HAMAP; MF_00235; Adenylate_kinase_Adk; 1.
DR   HAMAP; MF_03171; Adenylate_kinase_AK1; 1.
DR   InterPro; IPR000850; Adenylat/UMP-CMP_kin.
DR   InterPro; IPR033690; Adenylat_kinase_CS.
DR   InterPro; IPR028582; AK1.
DR   InterPro; IPR006267; AK1/5.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR23359; PTHR23359; 1.
DR   PRINTS; PR00094; ADENYLTKNASE.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR01360; aden_kin_iso1; 1.
DR   PROSITE; PS00113; ADENYLATE_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation;
KW   Hereditary hemolytic anemia; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    194       Adenylate kinase isoenzyme 1.
FT                                /FTId=PRO_0000158910.
FT   NP_BIND      18     23       ATP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   NP_BIND      65     67       AMP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   NP_BIND      94     97       AMP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   REGION       38     67       NMPbind. {ECO:0000255|HAMAP-
FT                                Rule:MF_03171, ECO:0000269|Ref.11,
FT                                ECO:0000269|Ref.12}.
FT   REGION      131    141       LID. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   BINDING      39     39       AMP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   BINDING      44     44       AMP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   BINDING     101    101       AMP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   BINDING     132    132       ATP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   BINDING     138    138       AMP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   BINDING     149    149       AMP. {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   BINDING     177    177       ATP; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03171,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT   MOD_RES       1      1       N-acetylmethionine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03171,
FT                                ECO:0000269|PubMed:183954}.
FT   MOD_RES      38     38       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT      40     40       G -> R (in HAAKD; dbSNP:rs137853204).
FT                                {ECO:0000269|PubMed:12649162}.
FT                                /FTId=VAR_055337.
FT   VARIANT      64     64       G -> R (in HAAKD; dbSNP:rs137853205).
FT                                {ECO:0000269|PubMed:12649162}.
FT                                /FTId=VAR_055338.
FT   VARIANT     123    123       E -> Q (in dbSNP:rs8192462).
FT                                /FTId=VAR_034046.
FT   VARIANT     128    128       R -> W (in HAAKD; dbSNP:rs28930974).
FT                                {ECO:0000269|PubMed:2542324}.
FT                                /FTId=VAR_004021.
FT   VARIANT     140    140       Missing (in HAAKD).
FT                                {ECO:0000269|PubMed:12649162}.
FT                                /FTId=VAR_055339.
FT   VARIANT     164    164       Y -> C (in HAAKD; dbSNP:rs137853203).
FT                                {ECO:0000269|PubMed:9432020}.
FT                                /FTId=VAR_055340.
FT   CONFLICT      9      9       K -> N (in Ref. 5; AAH01116).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       Q -> R (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       S -> E (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX         1      5       {ECO:0000244|PDB:2C95}.
FT   STRAND       10     15       {ECO:0000244|PDB:2C95}.
FT   HELIX        21     32       {ECO:0000244|PDB:2C95}.
FT   STRAND       35     38       {ECO:0000244|PDB:2C95}.
FT   HELIX        39     48       {ECO:0000244|PDB:2C95}.
FT   HELIX        52     62       {ECO:0000244|PDB:2C95}.
FT   HELIX        69     83       {ECO:0000244|PDB:2C95}.
FT   TURN         84     86       {ECO:0000244|PDB:2C95}.
FT   STRAND       90     94       {ECO:0000244|PDB:2C95}.
FT   HELIX        99    108       {ECO:0000244|PDB:2C95}.
FT   STRAND      113    119       {ECO:0000244|PDB:2C95}.
FT   HELIX       122    133       {ECO:0000244|PDB:2C95}.
FT   STRAND      135    137       {ECO:0000244|PDB:2C95}.
FT   HELIX       139    141       {ECO:0000244|PDB:2C95}.
FT   HELIX       143    156       {ECO:0000244|PDB:2C95}.
FT   HELIX       158    167       {ECO:0000244|PDB:2C95}.
FT   STRAND      170    174       {ECO:0000244|PDB:2C95}.
FT   HELIX       179    193       {ECO:0000244|PDB:2C95}.
SQ   SEQUENCE   194 AA;  21635 MW;  95EC5AAA92D1F00F CRC64;
     MEEKLKKTKI IFVVGGPGSG KGTQCEKIVQ KYGYTHLSTG DLLRSEVSSG SARGKKLSEI
     MEKGQLVPLE TVLDMLRDAM VAKVNTSKGF LIDGYPREVQ QGEEFERRIG QPTLLLYVDA
     GPETMTQRLL KRGETSGRVD DNEETIKKRL ETYYKATEPV IAFYEKRGIV RKVNAEGSVD
     SVFSQVCTHL DALK
//
